Fig. 2From: The impact of the COVID-19 pandemic on rates of adolescents receiving psychopharmacological medication in AustriaPrescription rate developments and forecasts for antipsychotics stratified by age and sex group. Age groups (10–14 years, 15–19 years, all age groups combined, including adults) according to gender from Quarter 1 (Q1) of 2013 to Quarter 4 (Q4) of 2021Back to article page